Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2000
02/02/2000EP0584136B1 Determination of motifs of peptides on mhc molecules
02/02/2000EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants
02/02/2000CN1243544A Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
02/01/2000US6020478 Human tumor-associated antigen
02/01/2000US6020477 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme
02/01/2000US6020468 Antibodies directed against binding-associated epitopes
02/01/2000US6020467 Antibodies against sulfotransferase
02/01/2000US6020466 Myeloid cell leukemia associated gene mcl-1
02/01/2000US6020462 Nucleic acids encoding the hypoxia inducible factor-1
02/01/2000US6020461 Detection of gonorrhea is one area in which nucleic acid hybridization holds great potential as a diagnostic tool in clinical medicine.
02/01/2000US6020327 Control of hair growth
02/01/2000US6020312 Synthetic antibiotics
02/01/2000US6020212 Phycobiliprotein-linker peptide complex fluorescent tracer and methods of using the same
02/01/2000US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent
02/01/2000US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use
02/01/2000US6020188 Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof
02/01/2000US6020182 Subunit respiratory syncytial virus vaccine preparation
02/01/2000US6020179 Nucleic acids encoding human tyrosine phosphatases
02/01/2000US6020170 Method of preparing a monoclonal antibody
02/01/2000US6020165 Cytikine signal regulators
02/01/2000US6020164 Human RNA binding proteins
02/01/2000US6020163 Lipocalin homolog
02/01/2000US6020161 PIGR-1, a member of immunoglobulin gene superfamily
02/01/2000US6020159 3-dehydroquinate synthase
02/01/2000US6020157 Polynucleotides encoding HFGAN72X receptor
02/01/2000US6020154 H. influenzae HxuB and HxuC genes, proteins and methods of use
02/01/2000US6020153 Chimeric antibodies
02/01/2000US6020152 Lymphocyte-associated cell surface protein
02/01/2000US6020148 In vitro method for eye and skin irritation testing
02/01/2000US6020146 Carcinogenicity testing system
02/01/2000US6020145 Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
02/01/2000US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease.
02/01/2000US6020140 Autoantibodies and their targets in the diagnosis of peripheral neuropathies
02/01/2000US6020133 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use
02/01/2000US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
02/01/2000US6019972 Peptides of human T cell reactive feline protein (TRFP)
02/01/2000US6019969 Composition comprising antibody to macrophage-derived inflammatory mediator (MIP-α 1 and MIP-1β)
02/01/2000US6019967 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
02/01/2000CA2171982C Drug binding protein
02/01/2000CA2047681C Vaccines for nontypable haemophilus influenzae
02/01/2000CA2009198C Monoclonal antibody for differentiating hiv-2 from hiv-1 seropositive individuals
02/01/2000CA1340888C Vaccines and diagnostic assays for haemophilus influenzae
02/01/2000CA1340887C Sialic acid glycosides, antigens, immunoadsorbents, and methods for thier preparation
01/2000
01/27/2000WO2000004383A2 Hiv group o positive control
01/27/2000WO2000004183A1 Bone morphogenic protein
01/27/2000WO2000004150A1 Human presenilin-associated protein
01/27/2000WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer
01/27/2000WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof
01/27/2000WO2000004140A1 71 human secreted proteins
01/27/2000WO2000004137A1 Human aspartic proteases
01/27/2000WO2000004052A2 Soluble derivatives of anti-angiogenic peptides
01/27/2000WO2000004050A2 Neurotrophic growth factor
01/27/2000WO2000004048A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents
01/27/2000WO2000004041A2 Methods and molecules relating to cd39-like polypeptides
01/27/2000WO2000003732A1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses
01/27/2000WO2000003730A1 Urease based vaccine against helicobacter infection
01/27/2000WO2000003687A2 Potassium channel polypeptide and polynucleotide compositions
01/27/2000WO1999063930A3 Novel angiotensin receptor modulators and their uses
01/27/2000WO1999061040A3 USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE
01/27/2000WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof
01/27/2000WO1999059609A3 Use of hmg proteins for the preparation of medicaments having cytotoxic activity
01/27/2000WO1999054465A9 Gene encoding syntaxin interacting protein
01/27/2000DE19856301C1 Regulatory protein pKe83 from human epidermal keratinocytes and related nucleic acid, vectors and antibodies
01/27/2000CA2337835A1 Potassium channel polypeptide and polynucleotide compositions
01/27/2000CA2337511A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents
01/27/2000CA2335096A1 Methods and materials relating to novel cd39-like polypeptides
01/27/2000CA2334075A1 Bone morphogenic protein
01/27/2000CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer
01/27/2000CA2333929A1 Soluble derivatives of anti-angiogenic peptides
01/27/2000CA2333917A1 71 human secreted proteins
01/27/2000CA2333910A1 Neurotrophic growth factor
01/27/2000CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof
01/27/2000CA2333471A1 Human scad-related molecules, scrm-1 and scrm-2
01/27/2000CA2333467A1 Human presenilin-associated protein
01/27/2000CA2303062A1 Human aspartic proteases
01/26/2000EP0974841A2 Suppression of interference in immunoassays using substances derived from the framework regions of antibodies
01/26/2000EP0974671A1 Method for diagnosing bone dysbolism
01/26/2000EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy
01/26/2000EP0974651A1 Physiologically active protein originating in mammals
01/26/2000EP0974600A2 Anti-interleukin-18 antibody
01/26/2000EP0974057A1 Methods to detect hk2 polypeptides
01/26/2000EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
01/26/2000EP0973933A1 Immunological tolerance to hiv epitopes
01/26/2000EP0973928A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell
01/26/2000EP0973926A1 Adenoviral vectors with modified tropism
01/26/2000EP0973923A1 IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING
01/26/2000EP0973903A2 Protein for inhibiting apoptosis
01/26/2000EP0973897A1 Human tumor-associated membrane protein
01/26/2000EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
01/26/2000EP0973893A1 Intracellular amyloid-beta binding (erab) polypeptide
01/26/2000EP0973892A2 28 human secreted proteins
01/26/2000EP0973891A1 Human chemokine receptor-like chemokine
01/26/2000EP0973888A1 Dendritic cell-derived growth factor
01/26/2000EP0973879A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
01/26/2000EP0973876A1 DNA ENCODING $i(PNEUMOCYSTIS CARINII) PROTEASE
01/26/2000EP0973870A1 Methods for selecting germ-line competent cells in chicken embryos, and the use of the cells in the production of chimeras
01/26/2000EP0973867A1 Cell culture media for enhanced protein production
01/26/2000EP0973805A1 Method for production of antibodies to specific sites of rapamycin
01/26/2000EP0973804A2 Anti-vegf antibodies
01/26/2000EP0973803A1 Peptides useful for reducing symptoms of toxic shock syndrome